Cambridge biotech Alchemab has extended its Series A with a £25m British Business Bank investment, the lender’s largest in a life sciences company.

Cambridge biotech Alchemab has extended its Series A with a £25m British Business Bank investment, the lender’s largest in a life sciences company.

Alchemab Therapeutics Announces Largest Ever Life Sciences Investment From British Business Bank to Advance AI-Enabled Clinical Pipeline of Next Generation Human-Derived Antibodies